Name | Value |
---|---|
Revenues | 25.4M |
Cost of Revenue | 10.6M |
Gross Profit | 14.7M |
Operating Expense | 15.7M |
Operating I/L | -0.9M |
Other Income/Expense | 0.4M |
Interest Income | 0.9M |
Pretax | -0.6M |
Income Tax Expense | 0.7M |
Net Income/Loss | -1.2M |
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for fundamental research, discovery, and pre-clinical testing in the pharmaceutical and biotechnology industries, as well as in academic and government research laboratories. Its product line includes cellular and molecular technology instruments, tissue and organ-based lab research tools, precision scientific measuring instrumentation, and preclinical products. The company markets its offerings through various channels to reach research scientists and organizations, selling under well-known brand names such as Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS.